Anti-EphA4 antibody


Ontology type: sgo:Patent     


Patent Info

DATE

2021-10-05T00:00

AUTHORS

INOUE EIJI , YAMADA AKIO , KAWAKATSU TOMOMI , IMAI TOSHIO , DEGUCHI MAKI , NAKATANI AKI

ABSTRACT

Provided is an anti-EphA4 antibody that can bind to EphA4 and enhance the cleavage of EphA4, as well as a pharmaceutical composition comprising the antibody as the active ingredient. A mouse anti-EphA4 antibody that has binding affinity towards EphA4 and can enhance the cleavage of EphA4 was obtained, and the sequence of the complementarity-determining region (CDR) of the mouse anti-EphA4 antibody was identified. Subsequently, the anti-EphA4 antibody of interest was obtained by producing a humanized antibody of the mouse anti-EphA4 antibody. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "INOUE EIJI", 
        "type": "Person"
      }, 
      {
        "name": "YAMADA AKIO", 
        "type": "Person"
      }, 
      {
        "name": "KAWAKATSU TOMOMI", 
        "type": "Person"
      }, 
      {
        "name": "IMAI TOSHIO", 
        "type": "Person"
      }, 
      {
        "name": "DEGUCHI MAKI", 
        "type": "Person"
      }, 
      {
        "name": "NAKATANI AKI", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nn994", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037079838", 
          "https://doi.org/10.1038/nn994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nj0417", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056460964", 
          "https://doi.org/10.1038/nj0417"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/45159", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015651802", 
          "https://doi.org/10.1038/45159"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027377235", 
          "https://doi.org/10.1038/nm.2901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm1406", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005035720", 
          "https://doi.org/10.1038/nrm1406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00308809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000355620", 
          "https://doi.org/10.1007/bf00308809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/256495a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001387921", 
          "https://doi.org/10.1038/256495a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nn1630", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050863948", 
          "https://doi.org/10.1038/nn1630"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35104061", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023675797", 
          "https://doi.org/10.1038/35104061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022336823", 
          "https://doi.org/10.1038/nrm856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13670-012-0006-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041627941", 
          "https://doi.org/10.1007/s13670-012-0006-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35041577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045506559", 
          "https://doi.org/10.1038/35041577"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-05T00:00", 
    "description": "

Provided is an anti-EphA4 antibody that can bind to EphA4 and enhance the cleavage of EphA4, as well as a pharmaceutical composition comprising the antibody as the active ingredient.

\n

A mouse anti-EphA4 antibody that has binding affinity towards EphA4 and can enhance the cleavage of EphA4 was obtained, and the sequence of the complementarity-determining region (CDR) of the mouse anti-EphA4 antibody was identified. Subsequently, the anti-EphA4 antibody of interest was obtained by producing a humanized antibody of the mouse anti-EphA4 antibody.

", "endDate": "2040-07-13", "id": "sg:patent.US-11136400-B2", "name": "Anti-EphA4 antibody", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.418765.9", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-11136400-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-10-01T07:03", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/patent/patent_51.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-11136400-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-11136400-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-11136400-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-11136400-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

94 TRIPLES      15 PREDICATES      28 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-11136400-B2 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N46ca03a3f7384a53a8e5f5c0ef464d1c
4 schema:citation sg:pub.10.1007/bf00308809
5 sg:pub.10.1007/s13670-012-0006-5
6 sg:pub.10.1038/256495a0
7 sg:pub.10.1038/35041577
8 sg:pub.10.1038/35104061
9 sg:pub.10.1038/45159
10 sg:pub.10.1038/nj0417
11 sg:pub.10.1038/nm.2901
12 sg:pub.10.1038/nn1630
13 sg:pub.10.1038/nn994
14 sg:pub.10.1038/nrm1406
15 sg:pub.10.1038/nrm856
16 schema:datePublished 2021-10-05T00:00
17 schema:description <p id="p-0001" num="0000">Provided is an anti-EphA4 antibody that can bind to EphA4 and enhance the cleavage of EphA4, as well as a pharmaceutical composition comprising the antibody as the active ingredient.</p> <p id="p-0002" num="0000">A mouse anti-EphA4 antibody that has binding affinity towards EphA4 and can enhance the cleavage of EphA4 was obtained, and the sequence of the complementarity-determining region (CDR) of the mouse anti-EphA4 antibody was identified. Subsequently, the anti-EphA4 antibody of interest was obtained by producing a humanized antibody of the mouse anti-EphA4 antibody.</p>
18 schema:endDate 2040-07-13
19 schema:name Anti-EphA4 antibody
20 schema:recipient grid-institutes:grid.418765.9
21 schema:sameAs https://app.dimensions.ai/details/patent/US-11136400-B2
22 schema:sdDatePublished 2022-10-01T07:03
23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
24 schema:sdPublisher N9f2b2cc2896043619dafe88fff2b78c5
25 sgo:license sg:explorer/license/
26 sgo:sdDataset patents
27 rdf:type sgo:Patent
28 N21e79dafc3b84d3786c5658c5410fd12 rdf:first N2b81752268f948c8a40d09d2f5b17c01
29 rdf:rest rdf:nil
30 N235df254ad4c422cbf1445f8080e5dae rdf:first N698d51b3a30445a28bbb7ba99833ed6f
31 rdf:rest Nd4605c87a3984916869f79ab9e40a4e4
32 N2b81752268f948c8a40d09d2f5b17c01 schema:name NAKATANI AKI
33 rdf:type schema:Person
34 N46ca03a3f7384a53a8e5f5c0ef464d1c rdf:first Nb0f3810364844c21a8dd4dbbf7e7cf27
35 rdf:rest Neb393603cdf6458fb9e3af29ee820265
36 N4ab41332afcf4bf5be3fc33ed75c73f3 schema:name YAMADA AKIO
37 rdf:type schema:Person
38 N5b4c0dc7059a4b8996635c09b6c58388 rdf:first Na76b71d251d24b5d9d415411a4f8abb5
39 rdf:rest N21e79dafc3b84d3786c5658c5410fd12
40 N698d51b3a30445a28bbb7ba99833ed6f schema:name KAWAKATSU TOMOMI
41 rdf:type schema:Person
42 N9f2b2cc2896043619dafe88fff2b78c5 schema:name Springer Nature - SN SciGraph project
43 rdf:type schema:Organization
44 Na76b71d251d24b5d9d415411a4f8abb5 schema:name DEGUCHI MAKI
45 rdf:type schema:Person
46 Na7c0954b4992411da25e589ce51113ea schema:name IMAI TOSHIO
47 rdf:type schema:Person
48 Nb0f3810364844c21a8dd4dbbf7e7cf27 schema:name INOUE EIJI
49 rdf:type schema:Person
50 Nd4605c87a3984916869f79ab9e40a4e4 rdf:first Na7c0954b4992411da25e589ce51113ea
51 rdf:rest N5b4c0dc7059a4b8996635c09b6c58388
52 Neb393603cdf6458fb9e3af29ee820265 rdf:first N4ab41332afcf4bf5be3fc33ed75c73f3
53 rdf:rest N235df254ad4c422cbf1445f8080e5dae
54 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
55 rdf:type schema:DefinedTerm
56 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
57 rdf:type schema:DefinedTerm
58 sg:pub.10.1007/bf00308809 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000355620
59 https://doi.org/10.1007/bf00308809
60 rdf:type schema:CreativeWork
61 sg:pub.10.1007/s13670-012-0006-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041627941
62 https://doi.org/10.1007/s13670-012-0006-5
63 rdf:type schema:CreativeWork
64 sg:pub.10.1038/256495a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001387921
65 https://doi.org/10.1038/256495a0
66 rdf:type schema:CreativeWork
67 sg:pub.10.1038/35041577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045506559
68 https://doi.org/10.1038/35041577
69 rdf:type schema:CreativeWork
70 sg:pub.10.1038/35104061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023675797
71 https://doi.org/10.1038/35104061
72 rdf:type schema:CreativeWork
73 sg:pub.10.1038/45159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015651802
74 https://doi.org/10.1038/45159
75 rdf:type schema:CreativeWork
76 sg:pub.10.1038/nj0417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056460964
77 https://doi.org/10.1038/nj0417
78 rdf:type schema:CreativeWork
79 sg:pub.10.1038/nm.2901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027377235
80 https://doi.org/10.1038/nm.2901
81 rdf:type schema:CreativeWork
82 sg:pub.10.1038/nn1630 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050863948
83 https://doi.org/10.1038/nn1630
84 rdf:type schema:CreativeWork
85 sg:pub.10.1038/nn994 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037079838
86 https://doi.org/10.1038/nn994
87 rdf:type schema:CreativeWork
88 sg:pub.10.1038/nrm1406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005035720
89 https://doi.org/10.1038/nrm1406
90 rdf:type schema:CreativeWork
91 sg:pub.10.1038/nrm856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022336823
92 https://doi.org/10.1038/nrm856
93 rdf:type schema:CreativeWork
94 grid-institutes:grid.418765.9 schema:Organization
 




Preview window. Press ESC to close (or click here)


...